Day at the Races: Comparing BioFire FilmArray Blood Culture ID Panels With Verigene Blood Culture Panel in Gram-Negative Bloodstream Infections Using DOOR-MAT Analysis
Kimberly C. Claeys, Kathryn Schlaffer, Richard T. Smith, Stephanie Hitchcock, Yunyun Jiang, Scott Evans, J. Kristie Johnson, Surbhi Leekha
Abstract
Three rapid diagnostic test panels (Verigene BC-GN, BioFire BCID, and BCID 2 [RUO]) were compared using the Desirability of Outcome Ranking Management of Antimicrobial Therapy (DOOR-MAT) to evaluate potential downstream antimicrobial prescribing decisions resulting from the panels' different organism and resistance detection. BioFire BCID 2 (RUO) had the best mean DOOR-MAT scores.
Topics & Concepts
GramBloodstream infectionBlood cultureMedicineMicrobiologyBiologyIntensive care medicineBacteriaGeneticsAntibioticsBacterial Identification and Susceptibility TestingStreptococcal Infections and TreatmentsInfective Endocarditis Diagnosis and Management